Scientific Presentations

Please join us at EURETINA 2024
for a Sponsored non-CME Educational Lunch Symposium

Improving on the Standard of Care in nAMD: Addressing the VEGF-C and -D Pathway

Prof. Arshad Khanani
MD, MA FASRS
University of Nevada Reno School of Medicine

Prof. Adnan Tufail
MBBS, MD, FRCOphth
The Institute of Ophthalmology, University College London

Prof. Anat Loewenstein
MD, MHA
Tel Aviv Medical Center

Prof. Gemmy Cheung
FRCOphth, FAMS, MCI
Singapore National Eye Centre

September 21, 2024
13:00-14:00 CEST • Room 211

Sponsored by

PRESENTATIONS

Introductions and Objectives
Speaker: A. Khanani, USA

 wAMD: Where are we today
• Disease Overview
Speaker: A. Tufail, UK

 Most recent and emerging Treatments in wAMD
• Treatment objectives for innovation in nAMD
• Review of most recent treatments
• Review of emerging treatments in Phase 3
Speaker: G. Cheung, Singapore

 Sozinibercept (OPT-302): An emerging therapy with the potential to raise the standard of care benchmark in visual outcomes
• An introduction to sozinibercept, a novel anti-VEGF C&D inhibitor
• Phase 2 data review
• Phase 3 Overview: Study Title and Objectives
Speaker: A. Loewenstein, Israel

 Panel Discussion
Moderator: A. Khanani, USA